SCHEMBL1369237

SCHEMBL1369237

O=C(/C=C/c1ccc(Cl)cc1Cl)c1cc2cc(Br)ccc2sc1=O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.56
LMNA P02545 7/20 0.56
ALDH1A1 P00352 6/20 0.56
KMT2A Q03164 6/20 0.56
MEN1 O00255 4/20 0.56
POLB P06746 4/20 0.56
RAB9A P51151 4/20 0.56
MCL1 Q07820 3/20 0.56
KDM4E B2RXH2 3/20 0.56
STAT3 P40763 2/20 0.56
NPSR1 Q6W5P4 1/20 0.56
L3MBTL1 Q9Y468 4/20 0.53
SMN1; SMN2 Q16637 3/20 0.53
GAA P10253 2/20 0.53
TP53 P04637 1/20 0.53
HPGD P15428 1/20 0.53
ALOX12 P18054 1/20 0.53
MAPK1 P28482 1/20 0.53
PTPN5 P54829 1/20 0.49
MAOB P27338 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1368861 1.00 MAPT (0.56) MAPTLMNAALDH1A1KMT2AMEN1
SCHEMBL1368860 1.00 MAPT (0.56) MAPTLMNAALDH1A1KMT2AMEN1
SCHEMBL1369174 0.92 PTPN5 (0.54) MAPTLMNAALDH1A1KMT2AMEN1
SCHEMBL1369175 0.92 PTPN5 (0.54) MAPTLMNAALDH1A1KMT2AMEN1
SCHEMBL1369450 0.92 PTPN5 (0.54) MAPTLMNAALDH1A1KMT2AMEN1
SCHEMBL1365828 0.86 STAT3 (0.55) MAPTLMNAALDH1A1KMT2AMEN1
SCHEMBL1368977 0.86 STAT3 (0.55) MAPTLMNAALDH1A1KMT2AMEN1
SCHEMBL1365826 0.86 STAT3 (0.55) MAPTLMNAALDH1A1KMT2AMEN1
SCHEMBL1366805 0.78 MAOB (0.53) MAPTKMT2AMEN1L3MBTL1MAPK1
SCHEMBL1366807 0.78 MAOB (0.53) MAPTKMT2AMEN1L3MBTL1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090275650-A1 3-Acyl coumarins, thiochromones and quinolones and therapeutic uses thereof TEMPLE UNIVERSITY- OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2009-11-05 US claimed
US-8067461-B2 3-acyl coumarins, thiochromones and quinolones and therapeutic uses thereof TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2011-11-29 US disclosed
US-20090275650-A1 3-Acyl coumarins, thiochromones and quinolones and therapeutic uses thereof TEMPLE UNIVERSITY- OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2009-11-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090275650-A1 3-Acyl coumarins, thiochromones and quinolones and therapeutic uses thereof NQO2, NQO1, HCCS MAPT 4718/4885LMNA 1399/4885ALDH1A1 617/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.